Mariarosaria Miloso

5PUBLICATIONS
8CO-AUTHORS
Molecular medicineMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721.

|Jan 21, 2023
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent.

Alessio Malacrida, Marie Deschamps-Wright, Roberta Rigolio

|Nov 11, 2022
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells.

Roberta Listro, Alessio Malacrida, Francesca Alessandra Ambrosio

|Jan 11, 2022
Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair.

Alessio Malacrida, Guido Cavaletti, Mariarosaria Miloso

|Nov 13, 2021
Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa-Part 2.

Alessio Malacrida, Valeria Cavalloro, Emanuela Martino

Pageof 1

Frequent Collaborators

4 joint publications

Guido Cavaletti

2 joint publications

Giosuè Costa

2 joint publications

Francesca Alessandra Ambrosio

2 joint publications

Simona Collina